BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sokratous M, Dardiotis E, Bellou E, Tsouris Z, Michalopoulou A, Dardioti M, Siokas V, Rikos D, Tsatsakis A, Kovatsi L, Bogdanos DP, Hadjigeorgiou GM. CpG Island Methylation Patterns in Relapsing-Remitting Multiple Sclerosis. J Mol Neurosci 2018;64:478-84. [PMID: 29516350 DOI: 10.1007/s12031-018-1046-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Cacabelos R, Cacabelos P, Carril JC. Epigenetics and Pharmacoepigenetics of Age-Related Neurodegenerative Disorders. Pharmacoepigenetics. Elsevier; 2019. pp. 903-50. [DOI: 10.1016/b978-0-12-813939-4.00038-3] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Kiselev IS, Kulakova OG, Boyko AN, Favorova OO. DNA Methylation As an Epigenetic Mechanism in the Development of Multiple Sclerosis. Acta Naturae 2021;13:45-57. [PMID: 34377555 DOI: 10.32607/actanaturae.11043] [Reference Citation Analysis]
3 Celarain N, Tomas-Roig J. Changes in Deoxyribonucleic Acid Methylation Contribute to the Pathophysiology of Multiple Sclerosis. Front Genet 2019;10:1138. [PMID: 31798633 DOI: 10.3389/fgene.2019.01138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Chan VS. Epigenetics in Multiple Sclerosis. Adv Exp Med Biol 2020;1253:309-74. [PMID: 32445101 DOI: 10.1007/978-981-15-3449-2_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Siokas V, Tsouris Z, Aloizou AM, Bakirtzis C, Liampas I, Koutsis G, Anagnostouli M, Bogdanos DP, Grigoriadis N, Hadjigeorgiou GM, Dardiotis E. Multiple Sclerosis: Shall We Target CD33? Genes (Basel) 2020;11:E1334. [PMID: 33198164 DOI: 10.3390/genes11111334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Andravizou A, Dardiotis E, Artemiadis A, Sokratous M, Siokas V, Tsouris Z, Aloizou AM, Nikolaidis I, Bakirtzis C, Tsivgoulis G, Deretzi G, Grigoriadis N, Bogdanos DP, Hadjigeorgiou GM. Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options. Auto Immun Highlights 2019;10:7. [PMID: 32257063 DOI: 10.1186/s13317-019-0117-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
7 Andravizou A, Artemiadis A, Bakirtzis C, Siokas V, Aloizou A, Peristeri E, Kapsalaki E, Tsimourtou V, Hadjigeorgiou GM, Dardiotis E. Brain volume dynamics in multiple sclerosis. A case-control study. Neurological Research 2019;41:936-42. [DOI: 10.1080/01616412.2019.1637041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Celarain N, Tomas-Roig J. Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients. J Neuroinflammation 2020;17:21. [PMID: 31937331 DOI: 10.1186/s12974-019-1667-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
9 Rikos D, Siokas V, Aloizou AM, Tsouris Z, Aslanidou P, Koutsis G, Anagnostouli M, Bogdanos DP, Grigoriadis N, Hadjigeorgiou GM, Dardiotis E. TREM2 R47H (rs75932628) variant is unlikely to contribute to Multiple Sclerosis susceptibility and severity in a large Greek MS cohort. Mult Scler Relat Disord 2019;35:116-8. [PMID: 31362167 DOI: 10.1016/j.msard.2019.07.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Dardiotis E, Aloizou AM, Siokas V, Patrinos GP, Deretzi G, Mitsias P, Aschner M, Tsatsakis A. The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis. J Mol Neurosci 2018;66:617-28. [PMID: 30415446 DOI: 10.1007/s12031-018-1204-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
11 Azari H, Karimi E, Shekari M, Tahmasebi A, Nikpoor AR, Negahi AA, Sanadgol N, Mousavi P. Construction of a lncRNA-miRNA-mRNA network to determine the key regulators of the Th1/Th2 imbalance in multiple sclerosis. Epigenomics 2021;13:1797-815. [PMID: 34726075 DOI: 10.2217/epi-2021-0296] [Reference Citation Analysis]
12 Siokas V, Katsiardanis K, Aloizou AM, Bakirtzis C, Liampas I, Koutlas E, Rudolf J, Ntinoulis K, Kountouras J, Dardiotis E, Deretzi G. Impact of Body Mass Index on the Age of Relapsing-Remitting Multiple Sclerosis Onset: A Retrospective Study. Neurol Int 2021;13:517-26. [PMID: 34698268 DOI: 10.3390/neurolint13040051] [Reference Citation Analysis]
13 Aloizou AM, Siokas V, Pateraki G, Liampas I, Bakirtzis C, Tsouris Z, Lazopoulos G, Calina D, Docea AO, Tsatsakis A, Bogdanos DP, Dardiotis E. Thinking outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke. J Clin Med 2021;10:630. [PMID: 33562264 DOI: 10.3390/jcm10040630] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nicaise AM, Wagstaff LJ, Willis CM, Paisie C, Chandok H, Robson P, Fossati V, Williams A, Crocker SJ. Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis. Proc Natl Acad Sci U S A 2019;116:9030-9. [PMID: 30910981 DOI: 10.1073/pnas.1818348116] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 24.0] [Reference Citation Analysis]
15 Zamani G, Hosseini Bereshneh A, Azizi Malamiri R, Bagheri S, Moradi K, Ashrafi MR, Tavasoli AR, Mohammadi M, Badv RS, Ghahvechi Akbari M, Heidari M. The First Comprehensive Cohort of the Duchenne Muscular Dystrophy in Iranian Population: Mutation Spectrum of 314 Patients and Identifying Two Novel Nonsense Mutations. J Mol Neurosci 2020;70:1565-73. [DOI: 10.1007/s12031-020-01594-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Diniz SN, da Silva CF, de Almeida IT, da Silva Costa FE, de Oliveira EML. INFβ treatment affects global DNA methylation in monocytes of patients with multiple sclerosis. J Neuroimmunol 2021;355:577563. [PMID: 33853016 DOI: 10.1016/j.jneuroim.2021.577563] [Reference Citation Analysis]
17 Hadjigeorgiou GM, Kountra PM, Koutsis G, Tsimourtou V, Siokas V, Dardioti M, Rikos D, Marogianni C, Aloizou AM, Karadima G, Ralli S, Grigoriadis N, Bogdanos D, Panas M, Dardiotis E. Replication study of GWAS risk loci in Greek multiple sclerosis patients. Neurol Sci 2019;40:253-60. [PMID: 30361804 DOI: 10.1007/s10072-018-3617-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
18 Dardiotis E, Tsouris Z, Aslanidou P, Aloizou A, Sokratous M, Provatas A, Siokas V, Deretzi G, Hadjigeorgiou GM. Body mass index in patients with Multiple Sclerosis: a meta-analysis. Neurological Research 2019;41:836-46. [DOI: 10.1080/01616412.2019.1622873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]